Emerging evidence suggests that the dysregulated activation or inhibition of Wnt5a signaling remains an important event in cancer progression, exerting both oncogenic and tumor suppressive effects depending on the availability of key receptors, thereby highlighting the paradoxical role of Wnt5a across different cancers [18]. The gene discussed is WNT5A; the disease is cancer.